GlassScriptPhysician profile
Hannah Baker
NPI 1891446902
$610.30
in general payments reported to CMS, 2019-2025
11 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $234 · 2024: $38.05 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $111.98 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.67 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $106.60 | 2023-2025 | Breztri, Farxiga |
| Exact Sciences Corporation | $79.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $43.20 | 2023-2025 | Repatha, Otezla, Repatha |
| Antares Pharma, INC. | $38.05 | 2024 | Xyosted |
| Novo Nordisk INC | $35.91 | 2023-2025 | Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $28.01 | 2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $25.85 | 2025 | |
| Glaxosmithkline, LLC. | $20.20 | 2023 | Trelegy Ellipta |
| Pfizer INC. | $13.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.